Caris Life Sciences, Inc.

NasdaqGS:CAI Stock Report

Market Cap: US$5.4b

Caris Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:CAI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Nov 25BuyUS$100,793J. DentonIndividual4,184US$24.09
07 Nov 25BuyUS$9,540David SpetzlerIndividual400US$23.85
20 Jun 25BuyUS$630,000Brian BrilleIndividual30,000US$21.00
20 Jun 25BuyUS$157,500J. DentonIndividual7,500US$21.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CAI?
Owner TypeNumber of SharesOwnership Percentage
State or Government9,4960.00308%
Private Companies9,778,8053.17%
VC/PE Firms39,642,01412.8%
Institutions122,612,50439.7%
Individual Insiders136,692,68444.3%

Dilution of Shares: CAI only recently listed within the past 12 months


Top Shareholders

Top 25 shareholders own 100.75% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
43.4%
David Halbert
122,545,546US$2.3b0%no data
10.8%
FMR LLC
30,631,585US$582.0m115%0.03%
7.17%
J.H. Whitney Capital Partners, LLC
20,256,615US$384.9m0%60.6%
6.86%
Sixth Street Partners, LLC
19,385,399US$368.3m-20.5%41.23%
4.96%
T. Rowe Price Group, Inc.
14,033,924US$266.6m-6.13%0.02%
3.67%
Peter Castleman
10,378,915US$197.2m0.08%no data
3.47%
Coatue Management, L.L.C.
9,819,992US$186.6m-3.18%0.41%
3.02%
Adapt I Ltd.
8,528,805US$162.0m0%no data
2.77%
Braidwell LP
7,816,142US$148.5m6.83%5.24%
2.38%
PointState Capital LP
6,718,707US$127.7m73%2.21%
1.36%
Millennium Management LLC
3,841,508US$73.0m-2.7%0.04%
1.34%
Neuberger Berman Investment Advisers LLC
3,800,922US$72.2m-12.5%0.05%
1.29%
UBS Asset Management AG
3,654,275US$69.4m170%0.01%
1.1%
OrbiMed Advisors LLC
3,116,011US$59.2m2.67%0.84%
1.1%
Citadel Advisors LLC
3,113,956US$59.2m0%0.04%
0.84%
BlackRock, Inc.
2,371,236US$45.1m266%no data
0.84%
JP Morgan Asset Management
2,366,415US$45.0m182%no data
0.66%
Point72 Asset Management, L.P.
1,864,860US$35.4m91.8%0.05%
0.59%
Balyasny Asset Management L.P.
1,660,280US$31.5m23,900%0.06%
0.58%
Eaton Vance Management
1,632,210US$31.0m0%0.01%
0.53%
Longaeva Partners L.P.
1,509,745US$28.7m17.4%3.63%
0.53%
Columbia Management Investment Advisers, LLC
1,505,080US$28.6m-10.4%0.01%
0.52%
Canada Pension Plan Investment Board
1,464,558US$27.8m10.7%0.01%
0.5%
ClearBridge Investments, LLC
1,416,207US$26.9m2.53%0.02%
0.48%
Jon Halbert
1,352,492US$25.7m1,250%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/01 15:09
End of Day Share Price 2026/05/01 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Caris Life Sciences, Inc. is covered by 14 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Michael RyskinBofA Global Research
Mark MassaroBTIG